| CTRI Number |
CTRI/2010/091/000499 [Registered on: 19/05/2010] |
| Last Modified On: |
|
| Post Graduate Thesis |
|
| Type of Trial |
|
|
Type of Study
|
|
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A study of the effect of vitamin D supplementation in pregnant women, on the growth and biochemical features of the newborn baby and infant. |
|
Scientific Title of Study
|
Vitamin D and calcium nutrition: deficiency and evaluation of supplementation. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vijayalakshmi Bhatia |
| Designation |
|
| Affiliation |
|
| Address |
Dept of endocrinology SGPGIMS, Raebareli Road Lucknow UTTAR PRADESH 226014 India |
| Phone |
+91-522-2494380 |
| Fax |
+91-522-2668017 |
| Email |
vbhatia@sgpgi.ac.in |
|
Details of Contact Person Scientific Query
|
| Name |
Vijayalakshmi Bhatia |
| Designation |
|
| Affiliation |
|
| Address |
Dept of endocrinology SGPGIMS, Raebareli Road Lucknow UTTAR PRADESH 226014 India |
| Phone |
+91-522-2494380 |
| Fax |
+91-522-2668017 |
| Email |
vbhatia@sgpgi.ac.in |
|
Details of Contact Person Public Query
|
| Name |
Vijayalakshmi Bhatia |
| Designation |
|
| Affiliation |
|
| Address |
Dept of endocrinology SGPGIMS, Raebareli Road Lucknow UTTAR PRADESH 226014 India |
| Phone |
+91-522-2494380 |
| Fax |
+91-522-2668017 |
| Email |
vbhatia@sgpgi.ac.in |
|
|
Source of Monetary or Material Support
|
| Indian Council for Medical Research |
|
|
Primary Sponsor
|
| Name |
Department of endocrinology, SGPGIMS, Lucknow |
| Address |
|
| Type of Sponsor |
|
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Department of obstetrics and gynecology, Queen Mary's Hospital, Chatrapati Sahuji Maharaj Medical University, Lucknow. |
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vijayalakshmi Bhatia |
Dept of endocrinology |
Sanjay Gandhi Postgraduate Institute of Medical Sciences,-226014 Lucknow UTTAR PRADESH |
+91-522-2668004 +91-522-2668017 vbhatia@sgpgi.ac.in |
| Dr Vinita Das |
Dept of Obstetrics and Gynecology |
Queen Mary's Hospital,Chhatrapati Sahuji Maharaj Medical University-226003 Lucknow UTTAR PRADESH |
+91-522-2257742 +91-522-2257742 das_lko@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics Committee of SGPGIMS, Lucknow |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
Vitamin D deficiency, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Oral calcium |
1 gm elemental calcium by mouth daily, as caclium carbonate without vitamin D. |
| Intervention |
Oral vitamin D3 |
Group 1 receives one sachet of 60,000 units of D3 by mouth, in mid trimester; group 2 receives 2 sachets in mid trimester and 2 sachets in 7th month of pregnancy. Both groups receive 1 gm elemental calcium as calcium carbonate, daily orally. |
|
|
Inclusion Criteria
|
| Age From |
|
| Age To |
|
| Gender |
|
| Details |
All pregnant women who attend antenatal clinic of one unit of Queen Mary Hospital, Chhatrapati Sahuji Maharaj Medical University, Lucknow, are recruited as subjects and randomised to receive one of the 2 intervention regimes. Consecutive women who attend antenatal clinic too near term to be included in the study to serve as controls. |
|
| ExclusionCriteria |
| Details |
Patients already on calcium or on vitamin D supplementation, on anticonvulsants, on antitubercular treatment or having any medical condition affecting calcium and vitamin D metabolism (e.g. renal or liver disease). |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Neonatal serum calcium |
At 4 to 6 day of life |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Baby weight, length, head circumference, anterior fontanelle diameter |
Birth |
| Baby weight, length, head circumference, anterior fontanelle diameter |
3 month of age |
| Baby weight, length, head circumference, anterior fontanelle diameter |
Six month of age |
| Baby weight, length, head circumference, anterior fontanelle diameter |
Nine month of age |
| Cord blood 25 OHD3 |
Birth |
| Cord blood alkaline phosphatase |
Birth |
|
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India=""
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
Date Missing |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
27/02/2006 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Completed |
| Recruitment Status of Trial (India) |
|
|
Publication Details
|
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
This is a pilot randomised study to see the efficacy of 2 dose regimens of oral vitamin D3 in pregnant women with regard to the following outcomes, in comparison with women who receive standard therapy of calcium alone: primary outcome: to maintain newborn serum calcium in better range, in other words, in preventing neonatal hypocalcemia; secondary aims: in maintaining better cord blood 25 OHD and alkaline phosphatase, ie, in preventing vitamin D deficiency in the baby, and the harmful effect of its deficiency on baby's bone health. Another secondary outcome: to maintain improved anthropometry of the baby at birth and at ages upto 1 year. |